In the world of experimental research, few compounds have garnered as much interest as the SS 31 peptide. Often discussed in the context of cellular energetics, this molecule—frequently referred to as Elamipretide, MTP-131, or Bendavia—has become a cornerstone for those focused on understanding mitochondrial healt SS-31 (also known as Bendavia, Elamipretide, and MTP-131) is a small peptide that accumulates in mitochondria and scavenges reactive oxygen species. h. As someone who follows the latest in laboratory research and investigative science, I have spent significant time reviewing the data surrounding this unique tetrapeptide.
Understandi Elamipretide SS-31 Peptide ng the Mechanism: What is SS 31?
At its core, SS 31 is a cell-permeable aromatic cationic tetrapeptide with a molecular SS-31 Peptide Guide 2026: Benefits, Dosage, Protocol & weight of approximately 639.8 g/mol. What makes it particularly fascinating to res SS31 ea SS-31 (also known as Bendavia, Elamipretide, and MTP-131) is a small peptide (D-Arg- dimethyl-Tyr-Lys-Phe-NH2) that accumulates in mitochondria and scavenges rchers is that it is designed to target mitochondria with high affinity.
When observing the literature, it becomes clear that this compound functions differently than standard antioxidants. It specifically binds to cardiolipin, a phospholipid found in the inner mitochondrial membrane. By doing so, it helps stabilize the mitochondrial structure, which is essential for efficient energy production. Many studies note that treatment with SS 31 restores redox homeostasis, effectively helping to neutralize the conditions that lead to cellular stress.
Why Researchers Study This Peptide
The primary objective for many labs utilizing SS 31 is to explore how it can reduce mitochondrial ROS production (reactive oxygen species). High levels of ROS are often associated with cellular degradation. By modulating these pathways, the peptide acts as an antioxidant peptide SS 31, protecting the integrity of the cell's "powerhouse."
In my own review of the available materials, I’ve noted that SS 31 is a mitochondria-targeted peptide that is used to study mitochondrial function across various models. Whether it is a 10 mg vial or a SS 31 50mg supply, the consistency of the lyophilized powder is crucial for those engaged in rigorous scientific inquiry.
Key Facts About the Molecule
* Chemical Identity: It is a small pept SS31 ide (D-Arg-dimethyl-Tyr-Lys-Phe-NH2).
* SS-31 Peptide | Cellular Energy & Repair Targeting: It is a unique tetrapeptide that specifically targets the mitochondria within cells.
* Regulatory Status: Notably, SS 31 is FDA-approved for Barth syndrome, a rare condition, which has brought significant attention to its potential applications.
* Terminology: You will often see it labeled as Elamipretide (MTP-131, SS 31) in various academic journals.
* Function: It is a mitochondria-targeting peptide that helps maintain the electron tra Sep 25, 2025 — The FDA has approved a first-of-its-kind mitochondrial therapy in the U.S. for the treatment of Barth syndrome, a rare condition that causes nsport chain's efficiency.
Integrating Research into Practice
When looking at the SS 31 peptide, it is important to remember that it is a synthetic peptide designed to target mitochondrial-related pathways. It is not a supplement for general wellness but rather a specialized tool for investigators.
In my experience analyzing the logs of those who utilize these compounds for research, the focus remains on the "why." Why does this peptide help in maintaining ATP production? The answer lies in its ability to prevent mitochondrial swelling and inhibit the release of cytochrome c. These are the technical benchmarks that define the utility of the peptide in a controlled laboratory setting.
Final Observations
For those curious about the 31 peptide, the landscape is vast. From studies on exercise tolerance to investigations into cellular repair, the data is compelling. While I view this strictly through the lens of scientific inquiry and personal interest in longevity research, the precision with which this molecule interacts with the inner mitochondrial membrane is remarkable.
As research continues into 2026, the focus will undoubtedly remain on how this mitochondria-targeting peptide can be utilized to better understand the complexities of cellular health. Whether you are reviewing a SS 31 peptide protocol or simply researching the molecule, the scientific consensus is clear: it remains a pivotal subject in the study of mitochondrial bioenergetics.